Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF
Subjects: NEUTRÓFILOS, EXPRESSÃO GÊNICA
ABNT
SANTIN, José Roberto et al. Role of a ppar-pan agonist and cyclooxygenase-2 inhibitor on neutrophil adhesion and migration induced by g protein-coupled receptor activation (GPCR). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 23 abr. 2024. , 2013APA
Santin, J. R., Machado, I. D., Drewes, C. C., Marcondes, R. S., Maia, D. C., Pitta, I. da R., & Farsky, S. H. P. (2013). Role of a ppar-pan agonist and cyclooxygenase-2 inhibitor on neutrophil adhesion and migration induced by g protein-coupled receptor activation (GPCR). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Santin JR, Machado ID, Drewes CC, Marcondes RS, Maia DC, Pitta I da R, Farsky SHP. Role of a ppar-pan agonist and cyclooxygenase-2 inhibitor on neutrophil adhesion and migration induced by g protein-coupled receptor activation (GPCR). Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 40 res. FCF075.[citado 2024 abr. 23 ]Vancouver
Santin JR, Machado ID, Drewes CC, Marcondes RS, Maia DC, Pitta I da R, Farsky SHP. Role of a ppar-pan agonist and cyclooxygenase-2 inhibitor on neutrophil adhesion and migration induced by g protein-coupled receptor activation (GPCR). Brazilian Journal of Pharmaceutical Sciences. 2013 ; 49 40 res. FCF075.[citado 2024 abr. 23 ]